​

Funding Round

Series C - Dermira

Series C - Dermira

Investment Firm

Overview

Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.

Announced Date

Aug 19, 2014

Closed on Date

Aug 21, 2014

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorUnion Chimique Belge
Participant InvestorBay City Capital
Participant InvestorAisling Capital
Participant InvestorCanaan Partners
Participant InvestorNew Enterprise Associates

Round Details and Background

Dermira raised $51000000 on 2014-08-19 in Series C

Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 12, 2016
Post-IPO Equity - Dermira
-1.5M
Aug 19, 2014
Series C - Dermira
8-51.0M
Jun 11, 2013
Series B - Dermira
4-35.0M
Oct 20, 2011
Series A - Dermira
3-42.0M

Recent Activity

There is no recent news or activity for this profile.